Navigation Links
VGI Medical Engages Ortho Spine Partners (OSP) to Lead US Commercialization Efforts
Date:1/10/2019

VGI Medical was founded in 2007 based on an invention developed by Tov Vestgaarden, PhD. It has become a leader in bringing innovation to the market including VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems are specifically designed to stabilize and fuse the facet joint by utilizing a unique patented dual geometric design to limit motion of the affected spinal segment. Applying the principles of this success, VGI Medical added SiJoin for Sacroiliac Fusion. VerteLP is one of the latest innovations offering an improved implant for lateral procedures featuring its proprietary Talon Technology.

Founded in 2015, Ortho Spine Partners has successfully led the commercialization efforts for several orthopedic and spine manufacturers. By focusing on creating a winning message and ensuring proper alignment between the surgeon, hospital and service rep, OSP has had multiple success stories including EIT Emerging Implant Technologies which was recently acquired by Johnson and Johnson Medical Device Companies.

“VGI has always focused on advancing technology by making the best products to improve the outcomes of the patients, yet being mindful of our surgeons’ needs to have easy to use instrumentation to complete a complex surgery. While VGI continues to develop products, with two new products expected to be released later this year, we are now making a concerted effort to focus on marketing the company and our products. We are thrilled OSP is eager to partner with us and take on this opportunity to advance VGI Medical to the next level.” said Tov Vestgaarden, founder and CEO of VGI Medical.

Co-Founder and President of Ortho Spine Partners, Josh Sandberg said: “We are very selective with the companies that we engage with. I am so pleased to establish a partnership with a company, like VGI Medical, that is dedicated to delivering the best possible products that improve the surgeon experience while delivering world class patient outcomes.”

“We are always looking to partner with companies that have a desire to bring clinical and economic value to the healthcare provider. VGI Medical has consistently demonstrated their desire to strategically partner with hospitals and ASCs to help them achieve their objectives in an everchanging healthcare environment,” said Chris J. Stewart, COO of Ortho Spine Partners.

About VGI Medical

VGI Medical is a disruptive force in the spinal implant industry by creating four unique technologies specifically designed to enhance patient outcomes and improve the overall surgeon experience. Our calling is to provide the ideal solution to each clinical challenge faced with the existing technologies on the market today. With over 12,500 implants used since our inception, our implants and instruments have been thoroughly tested with exceptional results. (http://www.vgimedical.com)

About Ortho Spine Partners

Ortho Spine Partners has created a unique platform to help companies in any stage commercialize their products in a very efficient way. We have worked closely with many organizations and produced results that have profoundly impacted each client’s business.

Our services are geared to meet you where you are today and help your business grow by utilizing proven industry executives that bring you an objective analysis and recommendations going forward. Our market knowledge is based on current trends and competitive analysis from industry stalwarts and some of the highest growth companies.

Ortho Spine Partners’ headquarters are in Scottsdale, Arizona but we have several offices across the US. (http://www.orthospinepartners.com).

Read the full story at https://www.prweb.com/releases/vgi_medical_engages_ortho_spine_partners_osp_to_lead_us_commercialization_efforts/prweb16021356.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Calidi Biotherapeutics Launches Scientific and Medical Advisory Board
2. Boulder iQ Offers 5 Resolutions for Medical Device Industry
3. Edmonton to Host Clinical Trial for Nova Oculus Medical Device that Could Help Improve Vision for AMD Sufferers
4. Argentum Medical Awarded $8.4M BARDA Contract for Silverlon Wound Technology to Prepare U.S. for Nuclear and Radiation Emergencies
5. Quick Specialized Healthcare Logistics Publishes New e-Book for the Medical Community
6. Voxx Analytics Announces Release of Voxx.Gateway for Medical Device and Early-Stage Life Science Companies
7. GlycoMark®, Inc. Announces Partnership with Premier Medical Laboratory Services to Expand Diabetes Test Menu
8. Nvision Biomedical Technologies Launches Pedicle Screw System at NASS
9. ComplianceOnline to Host 4th Medical Device Summit on June 7-8, 2018 in San Francisco, CA
10. The Giving Tree Wellness Center Introduces Kindred, an Upscale Medical Cannabis Collection
11. Medical Device Developer Promaxo Closes $3.5 Million Series A Funding Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2020)... ... June 29, 2020 , ... ... competitively procured purchasing contracts to its membership, recently named BioFit Engineered Products ... with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts ...
(Date:6/28/2020)... HILL, Conn. (PRWEB) , ... June 25, 2020 ... ... company formed to advance photodynamic therapy for treating cancer, today announced the company ... New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to ...
(Date:6/23/2020)... ... June 22, 2020 , ... ... Amniosomes special offer. This includes buy three, get the fourth unit free with ... , Amniotic derived exosomes, known as exosomes, have been a game changer for ...
(Date:6/11/2020)... ... June 08, 2020 , ... ... delivered through the use of proprietary clean viral vectors, recently announced a key ... States. Greffex’s platform is the world’s most successful gene therapy delivery vehicle ...
Breaking Biology Technology:
(Date:5/28/2020)... ... May 27, 2020 , ... Today bioinformatics ... a solution that uniquely combines lab testing insights and hc1’s exclusive Local Risk ... ongoing health and safety of employees returning to the workplace. , “Some of ...
(Date:5/28/2020)... (PRWEB) , ... May 28, 2020 , ... ... today that interim results from their 1801 Phase 1/2 study (NCT03678883, EudraCT #: ... Annual Meeting which will take place virtually on May 29th, 2020. Dr. Benedito ...
(Date:5/25/2020)... ... ... Oxford Nanopore Technologies is in advanced development of a new generation of ... , The LamPORE assay is designed to be rapid, low cost, and scalable ... samples. Hardware and reagents sit outside current, squeezed supply chains for other molecular ...
Breaking Biology News(10 mins):